Skip to content

    Tube Investments of India Limited

    TIINDIA
    Automobile and Auto Components·17 May 2025
    Management Summary

    Tube Investments reported a mixed Q4 FY25, with strong consolidated revenue growth driven by the EV segment's improved performance and a significant railway contract win. However, core engineering and metal formed products faced margin pressures and slight revenue declines. The company is focused on achieving operational break-even for its EV businesses within FY26 and resolving delays in medical device certifications.

    Highlights

    5
    • Consolidated revenue for Q4 FY25 was ₹5,150 Crores, up 14.7% from ₹4,490 Crores in the previous year.

    • PBT before exceptional items and CCPS fair value gain for Q4 FY25 was ₹327 Crores, a 2.8% increase from ₹318 Crores in the previous year.

    • Mobility segment's PBIT for Q4 FY25 was ₹4 Crores, a significant improvement from a loss of ₹9 Crores in the prior year, with revenue growing 20.6% YoY to ₹181 Crores.

    • A ₹1,000 Crores railway contract for the Metal Formed Products business was signed, expected to revive the segment's growth and margins from Q4 FY26.

    • The company aims for operational break-even for two of its EV businesses within the current financial year (FY26).

    Concerns

    5
    • Engineering division revenue for Q4 FY25 declined 3.7% YoY to ₹1,229 Crores, with PBIT down 11.25% to ₹142 Crores.

    • Metal Formed Products PBIT for Q4 FY25 declined 7.14% YoY to ₹39 Crores, despite a 4.4% revenue growth.

    • The EV business reported a PBIT loss of ₹107 Crores for Q4 FY25 and ₹412 Crores for the full year FY25.

    • Delay in obtaining CE certifications for medical devices exports, impacting revenue generation from invested fixed costs.

    • A fair value loss of ₹137 Crores (investor portion) was recognized in the consolidated P&L due to the variable conversion nature of CCPS in TI Clean Mobility.

    What Changed1

    vs Q1 FY26

    Guidance items7 → 6 (-1)

    Key financials

    Single quarter

    04 metrics
    1. 01Revenue (Standalone)₹1,957 Cr-0.3%YoY
    2. 02PBT (excl. exceptional & CCPS FV gain)₹327 Cr+2.8%YoY
    3. 03Consolidated Revenue₹5,150 Cr+14.7%YoY
    4. 04Free Cash Flow₹225 Cr

    Segment breakdown

    • Engineering₹1,229 Cr59.7%
    • Metal Formed Products₹403 Cr19.6%
    • Mobility₹181 Cr8.8%
    • Others₹244 Cr11.9%
    Donut· Share of Revenue (Q4)

    Order Book

    high confidence

    Total Value

    ₹ 1,000 crores

    as of 2025-03-31

    quantified

    Inflow this qtr

    ₹ 1,000 crores

    Execution

    next seven years period of time

    "A significant railway contract has been signed, providing long-term revenue visibility for the Metal Formed Products division."

    Source:
    Prepared remarks

    Capital allocation

    4
    high confidence
    CategoryHeadline
    Capex

    ₹300 crores

    Debt

    Debt disclosed

    Dividend

    ₹1.5/share (final)

    Liquidity

    Cash ₹940 crores

    Cash of ₹940 Crores is available, covering more than one-and-a-half to two years of operational needs.

    Guidance & targets

    6
    CategoryTargetPriority
    Profitability
    EV Business Operational Break-even (2 businesses)
    Operational break-even
    High
    Profitability
    ROCE on Investments
    More than 25%
    High
    Revenue
    EV Business Revenue
    $1 billion
    High
    Market Share
    EV Business Market Position
    Top three players
    High
    Growth
    Engineering Division Growth
    Double digit growth
    Medium
    Capacity Utilization
    Nasik Plant Capacity Utilization
    Fully utilized
    High

    Medical device CE certifications completion

    next quarter
    CurrentDelayed, work in progress
    TargetCertifications obtained

    Why it matters

    Completion is crucial for revenue generation from fixed investments in the medical devices export business.

    And there is a bit of delay in getting those certifications. And we are expecting it to be over in thisquarter.

    How to verify

    risks_and_concerns[risk='Delay in medical device certifications'].detail

    Risks & concerns

    5
    RiskSeverity

    Uncertainty in export business

    Exports business continued to be 15% of TI sales, but there is a bit of uncertainty in the short run, viewed as temporary.Management acknowledged

    medium

    Delay in medical device certifications

    CE certifications for Europe exports are delayed, impacting revenue generation from invested fixed costs.Management acknowledged

    medium

    Stagnant/lower margins in Metal Formed Products

    MFPD business margins were under pressure due to slow railway segment activity, but a new contract is expected to improve this.Management acknowledged

    medium

    Competitive intensity in EV segment

    Increasing competition in the three-wheeler electric business and new entrants in the heavy electric truck segment.Analyst acknowledged

    medium

    CCPS fair value loss impacting P&L

    A fair value loss of ₹137 Crores was recognized in consolidated P&L due to variable conversion terms of CCPS in TI Clean Mobility.Management acknowledged

    medium

    Q&A highlights

    8

    “As of now, we are still studying for incubating another business line in TI. And regarding your question to PLI, we are yet to take call. We are also studying that option, but yet to conclude on that.”

    Analyst probed on future growth avenues and potential entry into electronic components, which management is still evaluating.

    asked by Rushabh Shah

    3 min read6 chapters

    Detailed Narrative

    01

    Q4 and Full Year FY25 Financial Performance Overview

    Tube Investments reported a standalone revenue of ₹1,957 Crores for Q4 FY25, a slight decrease from ₹1,962 Crores in the previous year. For the full year FY25, standalone revenue grew to ₹7,893 Crores from ₹7,611 Crores. PBT before exceptional items📎 and CCPS fair value gain for Q4 stood at ₹327 Crores, up from ₹318 Crores YoY, while the full-year figure was ₹975 Crores compared to ₹970 Crores. Consolidated revenue for Q4 FY25 was ₹5,150 Crores, marking a 14.7% increase over ₹4,490 Crores in the corresponding quarter of the previous year.

    02

    Segmental Performance and Outlook

    The Engineering division's Q4 revenue was ₹1,229 Crores, a 3.7% decline YoY, with PBIT at ₹142 Crores, down 11.25%. However, full-year revenue grew 2.2% to ₹5,029 Crores, with PBIT remaining flat at ₹617 Crores. The Metal Formed Products segment saw Q4 revenue increase 4.4% to ₹403 Crores, but PBIT declined 7.14% to ₹39 Crores. A significant ₹1,000 Crores railway contract, starting in Q4 FY26, is expected to revive this segment. The Mobility (EV) segment's Q4 revenue surged 20.6% to ₹181 Crores, turning profitable with a PBIT of ₹4 Crores from a ₹9 Crores loss last year.

    03

    EV Business Strategy and Milestones

    The TI Clean Mobility (TICMPL) business achieved its best-ever Q4, with total FY25 volumes across its four businesses reaching 7,540 units. IPL Tech deployed 65 trucks in Q4, contributing to 172 trucks out of 206 deployed industry-wide in FY25. The company is working towards achieving operational break-even for at least two of its EV businesses within the current financial year (FY26). Long-term targets include reaching a $1 billion revenue mark within the next three to four years and becoming a top three player in each of its four EV segments. The company is also indigenizing microcontrollers for its EV components.

    04

    Capital Allocation and Liquidity

    The company plans to invest approximately ₹300 Crores in its core business for FY26, with further investments earmarked for TI Medical, CDMO, and other new opportunities. No new debt raise is planned, as the company currently holds ₹940 Crores in cash, which is deemed sufficient to cover operational needs for the next one-and-a-half to two years. The board recommended a final dividend of ₹1.5 per share for FY25, in addition to the interim dividend of ₹2 per share paid in March 2025.

    05

    Medical Devices and New Business Initiatives

    The medical devices division is experiencing delays in obtaining CE certifications for exports to Europe, which is impacting the realization of revenue from prior investments. Management expects these certifications to be completed in the next quarter. Construction for the CDMO business plant has commenced and is expected to be completed by Q3-Q4 FY26, with mass production to follow. The company also took impairment charges for Moshine (₹15 Crores) and Aerostrovilos (₹3.5 Crores) due to unfulfilled margin expectations and lack of progress, respectively.

    06

    CCPS Valuation and Financial Impact

    TI Clean Mobility raised ₹2,750 Crores through CCPS, with Tube Investments contributing ₹500 Crores and private equity firms ₹2,250 Crores. Due to the variable conversion nature of these CCPS, they are treated as a financial liability. A fair valuation, conducted after funding completion in June 2024, resulted in a ₹706 Crores fair value loss for TI Clean Mobility. This translated to a ₹569 Crores fair value gain for TI standalone, but a net ₹137 Crores fair value loss (investor portion) was recognized in the consolidated P&L for Q4 FY25.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.